Early window of diabetes determinism in NOD mice, dependent on the complement receptor CRIg, identified by noninvasive imaging

被引:84
作者
Fu, Wenxian [1 ]
Wojtkiewicz, Gregory [2 ]
Weissleder, Ralph [2 ,3 ]
Benoist, Christophe [1 ,3 ]
Mathis, Diane [1 ,3 ,4 ]
机构
[1] Harvard Univ, Sch Med, Div Immunol, Dept Microbiol & Immunobiol, Boston, MA 02115 USA
[2] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA
[3] Broad Inst MIT & Harvard, Cambridge, MA USA
[4] Harvard Stem Cell Inst, Cambridge, MA USA
基金
美国国家卫生研究院;
关键词
ALTERNATIVE PATHWAY; DENDRITIC CELLS; INFLAMMATION; ACTIVATION; MOUSE; MACROPHAGES; PROGRESSION; INHIBITOR; MONOCYTES; AUTOANTIBODIES;
D O I
10.1038/ni.2233
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
All juvenile mice of the nonobese diabetic (NOD) strain develop insulitis, but there is considerable variation in their progression to diabetes. Here we used a strategy based on magnetic resonance imaging (MRI) of magnetic nanoparticles to noninvasively visualize local effects of pancreatic-islet inflammation to predict the onset of diabetes in NOD mice. MRI signals acquired during a narrow early time window allowed us to sort mice into groups that would progress to clinical disease or not and to estimate the time to diabetes development. We exploited this approach to identify previously unknown molecular and cellular elements correlated with disease protection, including the complement receptor of the immunoglobulin superfamily (CRIg), which marked a subset of macrophages associated with diabetes resistance. Administration of a fusion of CRIg and the Fc portion of immunoglobulin resulted in lower MRI signals and diabetes incidence. In addition to identifying regulators of disease progression, we show here that diabetes is set at an early age in NOD mice.
引用
收藏
页码:361 / 368
页数:8
相关论文
共 37 条
[1]  
André-Schmutz I, 1999, EUR J IMMUNOL, V29, P245, DOI 10.1002/(SICI)1521-4141(199901)29:01<245::AID-IMMU245>3.3.CO
[2]  
2-F
[3]   Genetics, pathogenesis and clinical interventions in type 1 diabetes [J].
Bluestone, Jeffrey A. ;
Herold, Kevan ;
Eisenbarth, George .
NATURE, 2010, 464 (7293) :1293-1300
[4]   MHC-LINKED PROTECTION FROM DIABETES DISSOCIATED FROM CLONAL DELETION OF T-CELLS [J].
BOHME, J ;
SCHUHBAUR, B ;
KANAGAWA, O ;
BENOIST, C ;
MATHIS, D .
SCIENCE, 1990, 249 (4966) :293-295
[5]   Pancreatic islet blood perfusion in the nonobese diabetic mouse: Diabetes-prone female mice exhibit a higher blood flow compared with male mice in the prediabetic phase [J].
Carlsson, PO ;
Sandler, S ;
Jansson, L .
ENDOCRINOLOGY, 1998, 139 (08) :3534-3541
[6]   A Novel Inhibitor of the Alternative Pathway of Complement Attenuates Intestinal Ischemia/Reperfusion-Induced Injury [J].
Chen, Jie ;
Crispin, Jose C. ;
Lucca, Jurandir Dalle ;
Tsokos, George C. .
JOURNAL OF SURGICAL RESEARCH, 2011, 167 (02) :E131-E136
[7]   Inhibition of the alternative pathway of complement activation reduces inflammation in experimental autoimmune uveoretinitis [J].
Chen, Mei ;
Muckersie, Elizabeth ;
Luo, Chang ;
Forrester, John V. ;
Xu, Heping .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2010, 40 (10) :2870-2881
[8]   Imaging inflammation of the pancreatic islets in type 1 diabetes [J].
Denis, MC ;
Mahmood, U ;
Benoist, C ;
Mathis, D ;
Weissleder, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (34) :12634-12639
[9]   Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation [J].
Freeman, GJ ;
Long, AJ ;
Iwai, Y ;
Bourque, K ;
Chernova, T ;
Nishimura, H ;
Fitz, LJ ;
Malenkovich, N ;
Okazaki, T ;
Byrne, MC ;
Horton, HF ;
Fouser, L ;
Carter, L ;
Ling, V ;
Bowman, MR ;
Carreno, BM ;
Collins, M ;
Wood, CR ;
Honjo, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (07) :1027-1034
[10]   Myeloid-derived suppressor cells as regulators of the immune system [J].
Gabrilovich, Dmitry I. ;
Nagaraj, Srinivas .
NATURE REVIEWS IMMUNOLOGY, 2009, 9 (03) :162-174